Latest: FDA Approves New Biosimilar for Oncology Treatment

STAT+: Major U.S. drug manufacturing plant did not properly investigate cat hair, pests, and other problems, FDA finds

0 Mins
A major U.S. drug manufacturing plant did not properly investigate cat hair, pests, and other problems, the FDA found in a recent inspection report.
Tags:
📢

Advertisement

300x250 Banner

Recent Content

COPD Biologics: Early Treatment Insights

Pulmonology • 2 hours ago

Antihypertensive Medication Guidelines

Cardiology • 4 hours ago

Juvenile Arthritis Care Transition

Rheumatology • 6 hours ago